PEverpure

On July 7, 2026, Mallun Yen, a member of our Board of Directors, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(C). The plan provides for the sale of up to 11,942 shares of our common stock until the earlier of December 31, 2026, or when all shares under Ms. Yen's plans are sold.

On January 8, 2026, John Colgrove, our Chief Visionary Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading plan on behalf of the VCF Trust, The RWC Irrevocable Trust, The EEC Irrevocable Trust, the Colgrove Family Living Trust, and The Colgrove Family Charitable Remainder Trust, that is intended to satisfy the affirmative defense of Rule 10b5-1(c).The plan provides for the sale of up to an aggregate of up to 2,434,265 shares of our common stock on specified dates until the earlier of December 31, 2026, or when all the shares under Mr. Colgrove’s plan are sold.The actual number of shares to be sold under Mr. Colgrove's plan is not currently determinable because the number will vary based on the market price of our common stock at the time of settlement. During the fourth quarter of fiscal 2026, other than Mr. Colgrove, none of our directors or executive officers, as defined in Rule 16a-1(f), adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408.

On September 26, 2025, Charles Giancarlo, our Chief Executive Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c), which provides for the sale of up to 1,000,000 shares of our common stock on specified dates until the earlier of February 16, 2027, or when all the shares under Mr. Giancarlo’s plan are sold.

On January 16, 2025, Dan FitzSimons, our Chief Revenue Officer, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c), which provides for the sale of up to 67,129 shares of our common stock on specified dates until the earlier of April 16, 2026, or when all the shares under Mr. FitzSimon’s plan are sold. The actual number of shares subject to the trading arrangement under the Rule 10b5-1 trading plan may be lower due to our withholding of certain shares to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units.

On January 7, 2025, John Colgrove, our Chief Visionary Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading plan on behalf of the Colgrove Family Charitable Remainder Trust and the Colgrove Family Living Trust, that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The plan provides for the sale by The Colgrove Family Charitable Remainder Trust of up to 800,000 shares of our common stock on specified dates until the earlier of December 31, 2025, or when all the shares under Mr. Colgrove’s plan are sold. The plan provides for the sale by the Colgrove Family Living Trust of up to the greater of 200,000 shares of our common stock or the number of shares necessary to generate gross proceeds of $3,500,000 on specified dates until the earlier of December 31, 2025, or when the gross proceeds from all sales by the Colgrove Family Living Trust equal $3,500,000. The number of shares to be sold by the Colgrove Living Trust is not currently determinable because the number will vary based on the market price of our common stock at the time of settlement.

On April 18, 2024, Dan FitzSimons, our Chief Revenue Officer, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c), which provides for the sale of up to 77,155 shares of our common stock on specified dates until the earlier of April 18, 2025, or when all the shares under Mr. FitzSimon’s plan are sold. The actual number of shares subject to the trading arrangement under the Rule 10b5-1 trading plan may be lower due to our withholding of certain shares to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units.

On April 17, 2024, John Colgrove, our Chief Visionary Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading plan on behalf of the The Colgrove Family Charitable Remainder Trust, that is intended to satisfy the affirmative defense of Rule 10b5-1(c), which provides for the sale of up to 1,000,000 shares of our common stock on specified dates until the earlier of December 31, 2024, or when all the shares under Mr. Colgrove’s plan are sold.

On December 15, 2023, Scott Dietzen, a member of our Board of Directors, adopted a Rule 10b5-1 trading plan on behalf of the Scott Dietzen 2022 Revocable Trust that is intended to satisfy the affirmative defense of Rule 10b5-1(c), which provides for the sale of up to 272,541 shares of our common stock on specified dates until the earlier of April 1, 2025, or when all the shares under Dr. Dietzen's plan are sold.